New Delhi, March 25: The Drugs Controller of India has intensified regulatory surveillance against unauthorised sale and promotion of GLP-1-based weight loss drugs. The Ministry of Health and Family Welfare stated that these drugs, when used without proper medical supervision, may lead to serious adverse effects and related health risks. details with CTN read as under:-
|